Nucleoside analogues as chemotherapeutic agents: A review

Nucleosides and Nucleotides

Volumn 11, Issue 2-4, 1992, Pages 903-945

  Perigaud C ^a   Gosselin, G ^a   Imbach, J L ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 2' METHYLENECYTIDINE; 3 DEAZAURIDINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 5 (2 CHLOROETHYL) 2' DEOXYURIDINE; 5 (2 IODOVINYL) 2' DEOXYURIDINE; 6 AZACYTIDINE; ACICLOVIR; ACYCLIC NUCLEOSIDE; ADENOSINE DERIVATIVE; ANCITABINE; ANGUSTMYCIN C; AZACITIDINE; BAMICETIN; BLASTICIDIN S; COFORMYCIN; CYTARABINE; EDOXUDINE; FLOXURIDINE; FLUDARABINE PHOSPHATE; FLUOROURACIL; FORMYCIN; GANCICLOVIR; GEMCITABINE; IDOXURIDINE; MERCAPTOPURINE; NEOSIDOMYCIN; NEPLANOCIN A; NIKKOMYCIN; NUCLEOCIDIN; NUCLEOSIDE ANALOG; PUROMYCIN; RIBAVIRIN; TIOGUANINE; TRIFLURIDINE; TUBERCIDIN; UNCLASSIFIED DRUG; VIDARABINE; ZIDOVUDINE;

ARTICLE; CHEMOTHERAPY; GENE EXPRESSION REGULATION; IMMUNOMODULATION;

EID: 0026605647     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319208021748     Document Type: Article

References (219)

1. Antineoplastic and Immunosuppressive Agents; Sartorelli, A. C.; David, G. J., Eds; Springer-Verlag: Berlin, 1974.
2. Hirsch, M.S.; Kaplan, J.C. Sci. Amer, 1987, 256(4). 76-85.
3. Levene, P.A.; Jacobs, W.A.Chem. Ber., 1909, 42, 2474-2478.
4. Nucleic Acids in Chemistry and Biology,Blackburn, G. M.; Gait, M. J., Eds; IRL Press: Oxford, 1990.
5. The Biochemistry of the Nucleic Acids-Adams, R. L. P.; Knowler, J. T.; Leader, D. P., Eds; Chapman and Hall: London, 1986.
6. McCoss, M.; Robins, M.J. in The Chemistry of Antitumor Agents; Wilman,D.E.V., Eds; Blackie: Glasgow, 1990, pp. 261-298
7. Robins, R.K.; Kini, G.D. in The Chemistry of Antitumor Agents',Wilman, D. E. V., Ed.; Blackie: Glasgow, 1990, pp. 299-321.
8. Ueda, T. in Chemistry of Nucleosides and Nucleotides-,Townsend, L. B., Ed.; Plenum Press: New York, 1988, Vol. 1, Chapter 1, pp. 1-112.
9. Srivastava, C.; Robins, R.K.; Meyer, R.B. in Chemistry of Nucleosides and Nucleotides-,Towsend, L. B., Ed.; Plenum Press: New York, 1988, Vol. 1, Chapter 2, pp. 113-281.
10. Nucleoside Analogues, Chemistry, Biology and Medical Applications-,Walker, R. T.; DeClercq, E.; Eckstein, F., Eds; Nato Advanced Study Institutes Series, Series A: Life Sciences; Plenum Press: New York, 1979, Vol. 26.
11. Heidelberger, C. in reference 1, Part II, Chapter41, pp. 193-231.
12. Black, D.J.; Livingston, R.B. Drugs,1990, 39, 489-501.
13. Chabner, B.A. in Cancer and Chemotherapy; Crooke, S. T.; Prestayko, A. W., Eds; Academic Press: New York, 1981, Vol. 3, pp. 3-24.
14. The Anticancer Drugs-,Pratt, W. B.; Ruddon, R. W., Eds; Oxford University Press: New York, 1979.
15. Prusoff, W.H.; Fischer, P.M. in reference 10, pp. 281-318.
16. Heidelberger, C.; Danenberg, P.V.; Moran, R.G. in Advances in Enzym and Related Areas of Molecular Biology-,Meister, A., Ed.; Wiley, J.: New York, 1983, Vol. 54, pp. 57-119.
17. Broom, A.D.J. Med.Chem., 1989, 32, 2-7.
18. Randerath, K.; Tseng, W.C.; Harris, J.S.; Lu, L.J.W. in Recent Results in Cancer Research, Modified Nucleosides and Cancer:Nass, G., Ed.; Springer-Verlag: Berlin, 1983, Vol. 84, 283-297.
19. Paterson, A.R.P.; Tidd, D.M. in reference 1, Part II, Chapter 47, pp. 384-403.
20. Tidd, D.M.; Paterson, A.R.P. Cancer Res, 1974, 34, 738-746.
21. Le Page, G.A.; Junga, I.G.; Bowman, B. Cancer Res.,1964, 24, 835-840.
22. Le Page, G.A.; Junga, I.G. Mol. Pharmacol., 1967, 3, 37-43.
23. Le Page, G.A.;Can. J. Biochem.,1968, 46, 655-661.
24. Peery, A.; Le Page, G. A., Cancer Res.,1969, 29, 617-623.
25. Le Page, G. A.; Loo, T. L., in Cancer Medicine, Holland, J. F.; Frei, E., Eds; Lea and Febiger: Philadelphie, 1973, pp. 754-768.
26. Rossi, A. in reference 10, pp. 409-436.
27. Skoda, J. in reference 1, Part II, Chapter 45, pp.348-372.
28. Renis, H.E. Antibiotics Chemother.,1980, 27, 164-207.
29. Brockman, R. W.; Shaddix, S. C.; Williams, M.; Nelson, J. A.;Rose, L. M.; Schabel, F. M. in Chemistry, Biology and Clinical Uses of Nucleoside Analogues; Bloch, A., Ed.; Ann. N. Y. Acad. Sci., 1977, Vol.255, Part III, pp. 501-522.
30. Creasey, W. A. in reference 1, Part II, Chapter 42, pp. 232-256.
31. North, T. W.; Cohen, S. S. in Viral Chemotherapy [International Encyclopedia of Pharmacology and Therapeutics, Vol. III]; Shugar, D., Ed.; Pergamon Press LTD: Oxford, 1984, Vol. 1, Chapter 8, pp. 303-341.
32. Hadfield, A. F.; Sartorelli, A. C. Adv. Pharmacol. Chemother., 1984, 20, 21-67.
33. Burchenal, J.H.; Currie, V.E.; Dowling, M.D.; Fox, J.J.; Krakoff, I.H. in Chemistry and Clinical Uses of NucleosideAnalogs; Bloch, A., Ed.;Ann. N. Y. Acad. Sci.,1977, Vol. 255, Part II, pp. 202-212.
34. Chwang, T.L.; Fridland, A.; Avery, T.L.J. Med. Chem., 1983, 26., 280-283.
35. Braakhuis, B. J. M.; Van Dongen, G. A. M. S.; Vermorken, J. B.; Snow, G. B. Cancer Res., 1991,51,211-214.
36. Grunewald, R.; Abbruzzese, J. L.; Tarassoff, P.; Plunkett, W. Cancer Chemother. Pharmacol., 1991, 27, 258-262.
37. Baker, C.H.; Banzon, J.; Bollinger, J.M.; Stubbe, J. J. Med. Chem.,1991, 34. 1879-1884.
38. Matsuda, A.; Takenuki, K.; Tanaka, M.; Sasaki, T.; Ueda, T. J. Med. Chem., 1991, 34, 812-819.
39. Yamagami, K.; Fujii, A.; Arita, M.; Okumoto, T.; Sakata, S.; Matsuda. A.; Ueda, T. Cancer Res., 1991, 51, 2319-2323.
40. Comprehensive Virology; Fraenkel-Conrat, H.; Wagner, R. R., Eds; Plenum Publishing Corp.: New York, 1979.
41. Prusoff, W.H.; Lin, T.S.; Zucker, M. Antiviral Res.,1986, 6, 311-328.
42. Shannon, W.M. in Antiviral Agents and Viral Diseases of Man;Galasso, G. J., Ed.; Raven Press: New York, 1984, Chapter 3, pp. 55-121.
43. Robins, R.K.; Revenkar, G.R. in Antiviral Drug Development. A Multidisciplinary Approach-,De Clercq, E.; Walker, R. T., Eds; Nato Advanced Institutes Series, Series A: Life Sciences; Plenum Press: New York, 1987, Vol. 143, pp. 11-36.
44. Oberg, B. in Problems of Antiviral Therapy,Stuart-Harris, C. H.; Oxford, J., Eds; Academic Press: London, 1982, pp. 35-69.
45. Fischer, P.H.; Prusoff, W.H. in Chemotherapy of Viral Infections, Handbook of Experimental Pharmacology,Came, P. E.; Caliguiri, L. A., Eds; Springer-Verlag: Berlin, 1982, Vol. 61, Part A, Chapter 2, pp. 95-116.
46. De Clercq, E. in Advances in Drug Research; Testa, B., Ed.; Academic Press LTD: London, 1988, Vol. 17, pp. 1-59.
47. Mansuri, M.M.; Martin, J.C. in Annual Reports in Medicinal Chemistry; White, R. J., Ed.; Academic Press: New York, 1987, Vol. 22, Section III, Chapter 15, pp. 147-157.
48. Mansuri, M.M.; Martin, J.C. in Annual Reports in Medicinal Chemistry;Allen, R. C., Ed.; Academic Press: New York, 1988, Vol. 23, Section III, Chapter 13, pp. 161-170.
49. De Clercq, E. in Applied Virology Research;Kurstak, E.; Marusyk, R. G.; Murphy, F. A.; Van Regenmortel, M. H. V., Eds; Plenum Publishing Corporation, 1988, Vol. 1, pp. 219-232.
50. De Clercq, E. Chem. Scripta,1986, 26, 41-47.
51. De Clercq, E.; Walker, R.T. Pharmac. Ther., 1984, 26, 1-44.
52. De Clercq, E. in Targets for the Design of Antiviral Agents; De Clercq, E.;Walker, R. T., Eds; Nato Advanced Institutes Series, Series A: Life Sciences; Plenum Press: New York; 1983, Vol. 73, pp. 203-230.
53. De Clercq, E. in Problems of Antiviral Therapy; Stuart-Harris, C. H.; Oxford, J., Eds; Academic Press: London, 1982, pp. 295-314.
54. Robins, R.K. Chem. Eng. News, 1986, 64, 28-40.
55. Adenine Arabinoside: An Antiviral Agent; Pavan-Langston, D.; Buchanan,R. A. Alford, C.A., Eds; Raven-Press: New York, 1975.;
56. Alford, C. A., Eds; Raven-Press: New York, 1975.
57. Whitley, R.; Alford, C.A.; Hess, F.; Buchanan, R.A. Drugs, 1980, 20. 267-282.
58. Drach, J.C. in Target for the Design of Antiviral Agents; De Clercq, E.; Walker,R.T., Eds; Nato Advanced Institutes Series, Series A: Life Sciences; Plenum Press:NewYork, 1983, Vol. 33, pp. 231-257.
59. Park, N.H.; Pavan-Langston, D. in Chemotherapy of Viral Infections, Handbook of Experimental Pharmacology; Came, P. E.; Caliguiri, L. A., Eds; Springer-Verlag: Berlin, 1982, Vol. 61, Part A, Chapter 3, pp. 117-136.
60. Sacks, S.L.; Merigan, T.C.; Kaminska, J.; Fox, I.H.J. Clin. Invest., 1982, 69. 226-230.
61. Elion, G. B.; Furman, P. A.; Fyfe, J. A.; De Miranda, P.;Beauchamp, L.;Schaeffer, H. J. Proc. Natl Acad. Sci. USA, 1977,74, 5716-5720.
62. Schaeffer, H.J., Beauchamp, L.; De Miranda, P.; Elion, G.B.; Bauer, D.J.; Collins, P. Nature, 1978, 272, 583-585.
63. Martin, J.C.; Dvorak, C.A.; Smee, D.F.; Matthews, T.R.; Verheyden, J.P.H. J. Med. Chem., 1983, 26, 759-761.
64. Smee, D.F.; Martin, J.C.; Verheyden, J.P.H.; Matthews, T.R. Antimicrob. Agents Chemother., 1983, 23, 676-682.
65. Field, A.K.; Davies, M.E.; Dewitt, C.; Perry, H.C.; Liou, R.; Germershausen, J.; Karkas, J.D.; Ashton, W.T.; Johnston, D.B.R.; Tolman, R.L. Proc. Natl Acad. Sci. USA, 1983, 80, 4139-4143.
66. Ogilvie, K.K.; Cheriyan, U.O.; Radatus, B.K.; Smith, K.O.; Galloway, K.S.; Kennell, W.L. Can. J. Chem., 1982, 60, 3005-3010.
67. Smith, K.O.; Galloway, K.S.; Ogilvie, K.K.; Cheriyan, U.O. Antimicrob. Agents Chemother., 1982, 22, 1026-1030.
68. Freitas, V.R.; Smee, D.F.; Chernow, M.; Boehme, R.; Matthews, T.R. Antimicrob. Agents Chemother., 1985, 28, 240-245.
69. De Miranda, P.; Burnette, T.; Cederberg, D.; Blum, M. R.; Brodie, H. R.; Mills, J. Program Abstr. 26 and Intersci. Conf. Antimicrob. Agents Chemother., 1986, abst. n. 566.
70. Bowden, R. A.; Digel, J.; Reed, E. C.; Meyers, J. D., J. Infect. Dis., 1987, 156. 899-903.
71. Shepp, D. H.; Dandliker, P. S.; De Miranda, P. Ann. Intern. Med., 1985, 103. 368-373.
72. DeClercq, E. Nucleosides Nucleotides, 1991,10, 167-180.
73. Holy, A. Chem. Scripta, 1986, 26, 83-89.
74. Bronson, J. J.; Ghazzouli, I.; Hitchcock, M. J. M.; Webb II, R. R., Kern, E. R.; Martin, J. C. in Nucleotide Analogues as Antiviral Agents; Martin, J. C., Ed.; Am. Chem. Soc.: Washington DC, 1989, Chapter 6, pp. 88-102.
75. De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P. C. Nature, 1986, 323, 464-467.
76. Votruba, I.; Bernaerts, R.; Sakuma, T.; De Clercq, E.;Merta, A.; Rosenberg, I.;Holy, A., Mol. Pharmacol., 1987,32, 524-529
77. Snoeck, R.; Sakuma, T.; De Clercq, E.; Rosenberg, I.; Holy, A. Antimicrob. Agents Chemother., 1988,32, 1839-1844.
78. Bronson, J. J.; Ghazzouli, I.; Hitchcock, M. J. M.; Webb II, R. R.; Martin, J. C. J. Med. Chem., 1989,32, 1457-1463.
79. Montgomery, J.A. Antiviral Res., 1989, 12, 113-132.
80. Wolfe, M. S.; Borchardt, R. T. J. Med. Chem., 1991, 34, 1521-1530.
81. Poiez, B. J.; Ruscetti, F.W.; Reitz, M.S.; Kalyanamaran, V.S.; Gallo, R.C. Nature, 1981, 294, 268-271.
82. Barre-Sinoussi, F., Chermann, J. C.; Rey, R.; Nugeyre, M. T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Vezinet-Brun, F.; Rouzioux, C.; Rozenbaum, W.; Montagnier, L. Science, 1983, 220. 868-871.
83. Gallo, R. C.; Salahuddin, S.Z.; Popovic, M.; Shearer, G.M.; Kaplan, M.; Haynes, B.F.; Palker, T.J.; Redfield, R.; Olesky, J.; Safai, B.; White, G.; Foster, P.; Markham, P.D. Science, 1984, 224, 500-503.
84. Herdewijn, P.; De Clercq, E. in Design of Anti-AIDS Drugs; De Clercq, E., Ed.; Elsevier: Amsterdam, 1990, Vol. 14, pp. 141-174.
85. Sarin, P. S. Ann. Rev. Pharmacol., 1988, 28, 411-428.
86. Broder, S. in Human Retrovirus, Cancer, and AIDS-. Approaches to Prevention and Therapy; Bolognes, D., Ed.; Liss, A. R.: New York, 1988, Vol. 71, pp. 365-380.
87. De Clercq, E. Anticancer Res., 1987, 7, 1023-1038.
88. Cretton, E. M.; Xie, M.Y.; Bevan, R.J.; Goudgaon, N.M.; Schinazi, R.F.; Sommadossi, J.P. Mol. Pharmacol., 1990, 39, 258-266.
89. Kolata, G. Science, 1987, 235. 1464-1465.
90. Richman, D. D.; Fischl, M.A.; Grieco, M.H.; Gottlieb, M.S.; Volberding, P.A.; Laskin, O.L.; Leedom, J. M.; Groopman, J.E.; Mildvan, D.; Hischl, M.S.; Jackson, G.G.; Durack, D.T.; Phil, D.; Nusinoff-Lehrman, S. New Engl. J. Med., 1987, 317, 192-197.
91. Richman, D. D. Am. J. Med., 1990, 88, 8-10.
92. Larder, B.A.; Darby, G.; Richman, D.D. Science, 1989, 243.1731-1734.
93. Nasr, M.; Litterst, C.; Me Gowan, J. Antiviral Res., 1990,14, 125-148.
94. De Clercq, E. Antiviral Res., 1989, 12, 1-20.
95. Balzarini, J.; De Clercq, E. in Design of Anti-AIDS Drugs-, De Clercq, E. Ed.;Elsevier: Amsterdam, 1990, Vol. 14, pp. 141-174.
96. Miyasaka, T.; Tanaka, H.; Baba, M.; Hayakawa, H.; Walker, R. T.; Balzarini, J.; De Clercq, E. J. Med. Chem., 1989, 32, 2507-2509.
97. Tanaka, H.; Baba, M.; Hayakawa, H.; Haraguchi, K.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Walker, R.T.; De Clercq, E. Nucleosides Nucleotides, 1991,10, 397-400.
98. Tanaka, H.; Baba, M.; Hayakawa, H.; Sakamaki, T.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; Balzarini, J.; De Clercq, E. J. Med. Chem., 1991, 34. 349-357.
99. Tanaka, H.; Baba, M.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.;Shigeta, S.; Walker, R.T.; De Clercq, E.; Miyasaka, T. J. Med. Chem., 1991, 34,1394- 1399.
100. Tanaka, H.; Baba, M.; Saito, S.; Miyasaka, T.; Takashima, H.; Sekiya, K.; Ubasawa, M.; Nitta, I.; Walker, R. T.; Nakashima, H.; De Clercq, E. J. Med. Chem., 1991,34, 1511-1514.
101. Baba, M.;Tanaka, H.; De Clercq, E.; Pauwels, R.; Balzarini, J.; Schols, D.;Nakashima, H.; Perno, C.-F.; Walker, R.T.; Miyasaka, T. Biochem. Biophys.Res. Commun., 1989,165, 1375-1381.
102. Nucleoside Antibiotics; Suhadolnick, R. J., Ed.; Wiley-Interscience: NewYork, 1970.
103. Suhadolnick, R.J. in Progress in Nucleic Acid Research and Molecular Biology-, Cohn, W. E., Ed.; Academic Press: NewYork, 1979, Vol. 22, pp. 193-291.
104. Goodchild, J. Topics in Antibiotic Chemistry, 1982, 6, 99-228.
105. Buchanan, J. G.; Wightman, R. H. Topics in Antibiotic Chemistry, 1982, 6, 229-239.
106. Isono, K. J. Antibiotics, 1988, 41, 1711-1739.
107. Yagisawa, N.; Takita, T.; Ishizuka, M.; Takeuchi, T.; Umezawa, H. J. Antibiotics, 1982, 35, 435-759.
108. Nichol, C.A. in Handbook of Experimental Pharmacology-, Springer-Verlag: Berlin, 1975, Vol. 38, pp. 434-457.
109. Barett, A.G.M.; Lebold, S.A. J. Org. Chem., 1990, 55, 5818-5820.
110. Saksena, A. K.; Girijavallabhan, V. M.; Cooper, A. B.; Loebenberg, D. in Annual Reports in Medicinal Chemistry, Allen, R. C., Ed.; Academic Press: San Diego, 1990, Vol. 24, Section III, Chapter 12, pp. 111-120.
111. The Cellular Basis of the Immune Response, Golub, E. S., Ed.; Sinauer Associates: Massachusetts, 1981.
112. Essential Immunology, Roitt, I. M., Ed.; Blackwell Scientific Publications: Oxford,1984.
113. Samuel, C.E. in Progress in Nucleic Acid Research and Molecular Biology-, Cohn, W. E.; Moldave, K., Eds; Academic Press: NewYork, 1988, Vol. 35, pp. 27-72.
114. Sehgal, P. B.; Pfeffer, L.M.; Tamm, I. in Chemotherapy of Viral Infections, Handbook of Experimental Pharmacology-, Came, P. E.; Caliguiri, L. A., Eds; Springer-Verlag: Berlin, 1982, Vol. 61, Part A, Chapter 6, pp. 205-311.
115. Biological response modifiers-, Torrence, P. F., Ed.; Academic Press: NewYork, 1985.
116. Synthetic Adjuvants; Adam, A., Ed.; Wiley-Interscience: NewYork, 1985.
117. Hadden, J.W., J. Am. Med. Assoc., 1987, 258, 3005-3010.
118. Sl Georgiev V., Trends Pharmacol. Sci., 1988, 9, 446-451.
119. Weigle, W.O. C. R. C. Crit. Rev. Immunol., 1987, 7, 285-324.
120. Wicker, L.S.; Ashton, W.T.; Boltz, R.C.; Meurer, L.C.; Miller, B.J.; Nichols, E.A.; Sigal, N.H.; Tolman, R.L.; Peterson, L.B. Cell. Zmmunol., 1988,112, 156-165.
121. Feldbush, T.L.; Balias, Z.K. J. Immunol., 1985,134. 3204-3211.
122. Koo, G.C.; Jewell, M.E.; Manyak, C.L.; Sigal, N.H.; Wicker, L.S. J. Immunol., 1988,140. 3249-3252.
123. Henry, E. M.; Kini, G.D.; Larson, J.B.; Robins, R.K.; Alaghamandan, H.A.; Smee, D.F. J. Med. Chem., 1990, 33. 2127-2130.
124. Goodman, M. G.; Hennen, W.J. Cell. Immunol., 1986, 102. 395-402.
125. Bontems, R.J.; Anderson, J.D.; Smee, D.F.; Jin, A.; Alaghamandan, H.A.; Sharma, B.S.; Jolley, W.B.; Robins, R.K.; Cottam, H.B. J. Med. Chem., 1990, 33, 2174-2178.
126. Nagahara, K.; Anderson, J.D.; Kini, G.D.; Dailey, K.; Larson, S.B.; Smee, D.F.; Jin, A.; Jolley, W.B.; Robins, R.K.; Cottam, H.B. J. Med. Chem., 1990,33,407-415
127. Smee, D. F.; Alaghamandan, H.A.; Cottam, H.B.; Sharma, B.S.; Jolley, W.B.; Robins, R.K. Antimicrob. Agents Chemother., 1989,33, 1487-1492.
128. Smee, D. F.; Alaghamandan, H.A.; Cottam, H.B.; Jolley, W.B.; Robins, R.K. J. Biol. Response Mod., 1990, 9, 24-32.
129. Smee, D. F.; Alaghamandan, H.A.; Jin, A.; Sharma, B.S.; Jolley, W.B. Antiviral Res., 1990. 13. 91-102.
130. Smee, D.F., Alaghamandan, H.A.; Bartlett, M.L.; Robins, R.K. Antiviral Chem. Chemother., 1990,1, 47-52.
131. Smee, D. F.; Huffman, J.H.; Gessaman, A.C.; Huggins, J.W.; Sidwell, R.W. Antiviral Res., 1991,15, 229-239.
132. Goodman, M. G.; Weigle, W.O. Proc. Natl Acad. Sci. USA, 1984, 81, 862-866.
133. Goodman, M.G. J. Immunol.,1988, 141, 2394-2399.
134. Rollins-Smith, L.A.; Lawton, A.R. J. Mol. Cell. Immunol., 1988, 4, 9-19.
135. Watson, J.D.; Hopkins, N.H.; Roberts, J.W.; Argetsinger-Steitz, J.; Weiner, A.M. in Molecular Biology of the Gene; Gillen, J. R., Ed.; The Benjamin/Cummings, 1987, Vol. 1, Chapter 3, pp.65-94.
136. Schleif, R. Science, 1988, 241. 1182-1187.
137. Helene, C.; Lancelot, G. Prog. Biophys. Mol. Biol., 1982, 39, 1-168.
138. Green, P. J.; Pines, O.; Inouye, M. Annu. Rev. Biochem., 1986, 55, 569-597.
139. Simons, R. W.; Kleckner, N. Annu. Rev. Genetics, 1988, 22, 567-600.
140. Heywood, S. M. Nucl. Acids Res., 14, 6771-6772.
141. Paterson, B. M.; Roberts, B.E.; Kuff, E.L. Proc. Natl Acad. Sci. USA, 1977, 74, 4370-4374.
142. Stephenson, M. L.; Samecnik, P.C. Proc. Natl Acad. Sci. USA,, 1978, 75, 285-288.
143. Summerton, J. J. Theor. Biol., 1979, 78, 77-99.
144. Jayaraman, K.; McParland, K.; Miller, P.; Ts'o P. O. P. Proc. Natl Acad. Sci. USA, 1981, 78, 1537-1541.
145. Trudel, M.; Dondon, J.; Grunberg-Manago, M.; Finelli, J.; Buckingham, R.H. Biochimie, 1981, 63. 235-240.
146. Asseline, U.; Thuong, N. T.; Helene, C. C. R. Acad. Sci. Paris, 1983, 297 (3). 369-372.
147. Asseline, U.; Delarue, M.; Lancelot, G.; Toulme, F.; Thuong, N. T.; Montenay- Garestier, T.; Helene, C. Proc. Natl Acad. Sci. USA, 1984, 81, 3297-3301.
148. Asseline, U.; Toulme, F.; Thuong, N. T.; Delarue, M.; Montenay-Garestier, T.; Helene, C.; EM BO. J., 1984, 3, 795-800.
149. Knorre, D.G.; Vlassov, V. V. Prog. Nucl. Acid Res. Mol. Biol., 1985, 32, 291-320.
150. Helene, C.; Montenay-Garestier, T.; Saison, T.; Takasugi, M.; Toulme, J.J.; Asseline, U.; Lancelot, G.; Maurizot, J.C.; Toulme, F.; Thuong, N.T. Biochimie, 1985, 67, 777-783.
151. Takayama, K. M.; Inouye, M. Crit. Rev. Biochem. Mol. Biol., 1990, 25, 155-184.
152. Weintraub, H.; Izant, J. G.; Harland, R.M. Trends Genet., 1985,1, 22-25.
153. Izant, J. G.; Weintraub, H. Science, 1985, 229. 345-352.
154. Mizuno, T.; Chou, M.; Inouye, M. Proc. Natl Acad. Sci. USA, 1984, 81, 1966-1970.
155. Oligodeoxyribonucleotides, Antisense Inhibitors of Gene Expression, Topics in Molecular and Structural Biology; Cohen, J. S., Ed.; McMillan Press: London, 1989, Vol. 12.
156. Locke, S. L.; Stein, C.A.; Zhang, X.H.; Mori, K., Nakanishi, M.; Subasinghe, C.; Cohen, J.S.; Neckers, L.M.; Proc. Natl Acad. Sci. USA, 1989, 86. 3474-3478.
157. Wickstrom, E.J. Biochem. Biophys. Methods, 1986, 13,, 97-102.
158. Uhlmann, E.; Peyman, A. Chem. Rev., 1990, 90. 543-584.
159. Miller, P. S.; Fang, K.N.; Kondo, N.S.; Ts'o, P. O. P. J. Am. Chem. Soc., 1971, 93, 6657-6665.
160. Sproat, B. S.; Beijer, B.; Iribarren, A. Nucleic Acids Res., 1990, 18, 41-49, and references cited therein.
161. Rayner, B.; Malvy, C.; Paoletti, J.; Lebleu, B.; Paoletti, C.; Imbach, J. L. in reference 154, pp. 119-136.
162. Morvan, F.; Rayner, B.; Imbach J.L. in Genetic Engineering; Setlow, J. K., Ed.; Plenum Press: NewYork, 1990, 12, pp. 37-52.
163. Gagnor, C.; Bertrand, J. R.; Thenet, S.; Lemaitre, M.; Morvan, F.; Rayner, B.; Malvy, C.; Lebleu, B.; Imbach, J.L.; Paoletti, C.; Nucl. Acids Res., 1987, 15. 10419-10436.
164. Cazenave, C.; Stein, C. A.; Loreau, N.; Thuong, N.T.; Neckers, L.M.; Subasinghe, C.; Helene, C.; Cohen, J.S.; Toulme, J.J. Nucl. Acids Res., 1989, 17. 4255-4273.
165. Gagnor, C.; Rayner, B.; Leonetti, J. P.; Imbach, J.L.; Lebleu, B. Nucl. Acids Res., 1989,17, 5107-5114.
166. Paoletti, J.; Bazile, D.; Morvan, F.; Imbach, J. L.; Paoletti, C. Nucl. Acids Res., 1989,17, 2693-2704.
167. Ts'o, P.O.P.; Miller, P.S.; Greene, J.J. in Development of Target-Oriented Anticancer Drugs; Cheng, Y. C.; Goz, B.; Minkoff, M., Eds; Raven Press: NewYord, 1983, pp. 189-206.
168. Morvan, F.; Rayner, B.; Imbach, J. L.; Lee, M.; Hartley, J.A.; Chang, D.K.; Lown, J.W. Nucl. Acids Res., 1987,15, 7027-7044.
169. Morvan, F.; Rayner, B.; Imbach, J. L.; Thenet, S.; Bertrand, J.R.; Paoletti, J.; Malvy, C.; Paoletti, C. Nucleic Acids Res., 1987,15, 3421-3437.
170. Thenet, S.; Morvan, F.; Bertrand, J. R.; Gautier, C.; Malvy, C. Biochimie, 1988, 1729-1732.
171. Bacon, T. A.; Morvan, F.; Rayner, B.; Imbach, J.L.; Wickstrom, E.J. Biochem. Biophys. Methods, 1988,16, 311-312.
172. Pauwels, R.; Debyser, Z.; Baba, M.; Rayner, B.; Morvan, F.; Imbach, J. L.; De Clercq E., Arch. Int. Physiol. Biochim., 1988, 96, B-49.
173. Bloch, E.; Lavignon, M.; Bertrand, J. R.; Pognon, F.; Morvan, F.; Malvy, C.; Imbach, J. L.; Paoletti, C. Gene, 1988, 72. 349-360.
174. Damba, M. J.; Giannaris, P. A.; Marfey, P.; Reid, L. S. Tetrahedron Lett., 1991, 32, 2573-2576.
175. Morvan, F.; Genu, C.; Rayner, B.; Gosselin, G.; Imbach, J. L. Biochem. Biophys. Res. Commun., 1990, 172. 537-543.
176. Fujimori, S.; Shudo, K. J. Am. Chem. Soc., 1990, 112. 7436-7438.
177. Van Boeckel, C. C. A.; Visser, G. M.; Hegstrom, R.A.; Van Boom J. H., J. Mol. Evol., 1987,25, 100-105.
178. Anderson, D.J.; Reischer, D.J.; Taylor, A.J.; Wechter, W. J. Nucleosides Nucleotides, 1984, 3, 499-512.
179. Ogilvie, K. K.; Gillen, M.F. Tetrahedron Lett., 1980, 21, 327-330.
180. Ogilvie, K.K.; Nguyen-Ba, N.; Gillen, M.F.; Radatus, B.K.; Cheriyan, U.O.; Hanna, H.R.; Smith, K.O.; Galloway, K.S. Can. J. Chem., 1984, 62, 241-252.
181. Schneider, K. C.; Benner, S.A. J. Am. Chem. Soc., 1990, 112. 453-455.
182. Perbost, M.; Lucas, M.; Chavis, C.; Pompon, A.; Baugartner, H. Rayner, G.;Griengl, H.; Imbach, J.L. Biochem. Biophys. Res. Commun., 1989, 165. 742-747.
183. Sagi, J.; Szemzo, A.; Szecsi, J.; Otvos, L. Nucleic Acids Res., 1990, 18, 2133-2140.
184. Debart, F.; Rayner, B.; Imbach, J. L. Tetrahedron Lett., 1990, 31, 3537-3540.
185. Morvan, F.; Rayner, B.; Malvy, C.; Paoletti, J.; Paoletti, C.; Imbach, J. L. in Advances in Chemotherapy of AIDS; Diasio, R. B.; Sommadossi, J. P., Eds; Pergamon Press: New York, 1990, Chapter 2, pp. 11-22.
186. Miller, P. S. in Herpes Viruses, The Immune System and AIDS: Development in Medicinal Virology, Aurelian, L., Ed.; Klumer Academic: Norwell, 1990, Vol. 6, pp. 343-363.
187. Koga, M.; Moore, M. F.; Beaucage, S.L. J. Org. Chem., 1991, 56. 3757-3759.
188. Helene, C.; Toulme, J. J. Biochem. Biophys. Acta, 1990, 1049. 99-125.
189. Dervan, P. B. in reference 154, pp. 197-210.
190. Helene, C.; Toulme, J. J. in reference 154, pp. 137-172.
191. Goodchild, J. Bioconjugate Chem., 1990, 2, 165-187.
192. Zimmerman, T. P.; Domin, B.A.; Mahony, W.B.; Prus, K.L. Nucleosides Nucleotides, 1989, 8, 765-774.
193. Wang, C. C. Trends Biochem. Sci., 1982, 7, 354-356.
194. Wang, C. C. J. Med. Chem., 1984, 27, 1-9.
195. Jaffe, J.J. Ann. N. Y Acad. Sci., 1975, 255, 306-316.
196. Carson, D. A.; Chang, K.P. Biochem. Biophys. Res. Commun., 1981, 100. 1377-1383.
197. Nelson, D. J.; La Fon S.W.; Tuttle, J.V.; Miller, W.H.; Miller, R.L.; Krenitsky, T.A.; Elion, G.B.; Berens, R.L.; Marr, J.J. J. Biol. Chem., 1979, 254. 11544-11549.
198. Marr, J.J.; Berens, R.L.; Nelson, D.J.; Krenitsky, T.A.; Spector, T.; La Fon, S.W.; Elion, G.B. Biochem. Pharmacol., 1982,31, 143-148.
199. Rainey, P.; Santi, D. V. Proc. Natl Acad. Sci. USA, 1983, 80, 288-292.
200. Trivedi, B.K.; Blankley, C.J.; Bristol, J.A.; Hamilton, H.W.; Patt, W.C.; Kramer, W.J.; Johnson, S.A.; Bruns, R.F.; Cohen, D.M.; Ryan, M.J. J. Med. Chem., 1991, 34. 1043-1049.
201. Mittelman, A.; Evans, J. T.; Chheda, G.B. Ann. N. Y. Acad. Sci., 1975, 255. 225-234.
202. Hashizuma, T.; Yoshida, K. Agr. Biol. Chem., 1976, 40, 2001-2004.
203. Shibata, H.; Ohnishi, N.; Takeda, K.; Fukunaga, H.; Shimamura, K.; Yasunobu, E.; Tani, I. Can. J. Microbiol., 1986, 32, 186-189.
204. Sanger, F.; Nicklen, S.; Coulson, A. R. Proc. Natl Acad. Sci. USA, 1977, 74, 5463-5467.
205. Prober, J.M.; Trainor, G.L.; Dam, R.J.; Hobbs, F.W.; Robertson, C.W.; Zagursky, R.J.; Cocuzza, A.J.; Jensen, M.A.; Baumeister, K. Science, 1987, 238. 336-341.
206. Meggio, F.; Shugar, D.; Pinna, L. A. Eur. J. Biochem., 1990, 187. 89-94.
207. Stevens, A.; Maupin, M. K. Biochem. Biophys. Res. Commun., 1989, 159. 508-515.
208. Schneider, H. R.; Reichert, G.H.; Issinger, O.G. Eur. J. Biochem., 1986, 6, 733-738.
209. Perez, M.; Grande, J.; Itarte, E. FEBSLett., 1988, 238, 273-276.
210. Brunati, A. M.; Saggioro, D.; Chieco-Bianchi, L.; Pinna, L.A. FEBS Lett., 1986, 206. 59-63.
211. Issinger O.G.; Martin, T.; Richter, W.W.; Olson, M.; Fujiki, H. EMBOJ., 1988, 7, 1621-1627.
212. Sommercorn, J.; Krebs, E. G. J. Biol. Chem., 1987, 262. 3839-3843.
213. Haystead, T. A.; Campbell, D.G.; Hardie, D.G. Eur. J. Biochem., 1988, 175. 347-354.
214. Klarlund, J. E.; Czech, M.P. J. Biol. Chem., 1988, 263, 15872-15875.
215. Cadena, D.L.; Dahmus, M.E. J. Biol. Chem., 1987, 262, 12468-12474.
216. Horikoshi, M.; Nakanishi, Y.; Hiroshima, S.; Ohtsuki, M.; Kobayashi, T.; Natori, S. Chem. Pharm. Bull., 1987, 35, 4181-4187.
217. Zandomeni, R.D.; Carrera-Zandomeni, M.; Shugar, D.; Weinman, R.J. Biol. Chem., 1986, 261, 3414-3420.
218. Dahmus, M. E. J. Biol. Chem., 1981, 256, 3322-3339.
219. Braddock, M.; Thorbum, A.M.; Kingsman, A.J.; Kingsman, S.M. Nature, 1991, 35ft, 439-441.